Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future
Brian Godman,Mainul Haque,Judy McKimm,Muhamad Abu Bakar,Jacqueline Sneddon,Janney Wale,Stephen Campbell,Antony P. Martin,Iris Hoxha,Vafa Abilova,Bene D. Anand Paramadhas,Pinkie Mpinda-Joseph,Matshediso Matome,Lívia Lovato Pires de Lemos,Israel Abebrese Sefah,Amanj Kurdi,Sylvia Opanga,Arianit Jakupi,Zikria Saleem,Mohamed Azmi Hassali,Dan Kibuule,Joseph O Fadare,Tomasz Bochenek,Celia C. Rothe,Jurij Fürst,Vanda Marković-Peković,Ljubica Bojanić,Natalie Schellack,Johanna C Meyer,Zinhle Matsebula,Thuy Nguyen Thi Phuong,Binh Nguyen Thanh,Saira Jan,Aubrey Chichonyi Kalungia,Sekesai Mtapuri-Zinyowera,Massimo Sartelli,Ruaraidh Hill +36 more
Reads0
Chats0
TLDR
There is a need to document current practices and successful initiatives in LMICs to improve future antimicrobial use, and initiatives to reduce inappropriate prescribing and dispensing of antimicrobials for URTIs as part of NAPs and other activities, are monitored.Abstract:
Introduction: Antibiotics are indispensable to maintaining human health; however, their overuse has resulted in resistant organisms, increasing morbidity, mortality and costs. Increasing antimicrobial resistance (AMR) is a major public health threat, resulting in multiple campaigns across countries to improve appropriate antimicrobial use. This includes addressing the overuse of antimicrobials for self-limiting infections, such as upper respiratory tract infections (URTIs), particularly in lower- and middle-income countries (LMICs) where there is the greatest inappropriate use and where antibiotic utilization has increased the most in recent years. Consequently, there is a need to document current practices and successful initiatives in LMICs to improve future antimicrobial use. Methodology: Documentation of current epidemiology and management of URTIs, particularly in LMICs, as well as campaigns to improve future antimicrobial use and their influence where known. Results: Much concern remains regarding the prescribing and dispensing of antibiotics for URTIs among LMICs. This includes considerable self-purchasing, up to 100% of pharmacies in some LMICs. However, multiple activities are now ongoing to improve future use. These incorporate educational initiatives among all key stakeholder groups, as well as legislation and other activities to reduce self-purchasing as part of National Action Plans (NAPs). Further activities are still needed however. These include increased physician and pharmacist education, starting in medical and pharmacy schools; greater monitoring of prescribing and dispensing practices, including the development of pertinent quality indicators; and targeted patient information and health education campaigns. It is recognized that such activities are more challenging in LMICs given more limited resources and a lack of healthcare professionals. Conclusion: Initiatives will grow across LMICs to reduce inappropriate prescribing and dispensing of antimicrobials for URTIs as part of NAPs and other activities, and these will be monitored.read more
Citations
More filters
Journal ArticleDOI
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
Olayinka O Ogunleye,Debashis Basu,Debjani Mueller,Jacqueline Sneddon,R. Andrew Seaton,R. Andrew Seaton,Adesola F. Yinka-Ogunleye,Joshua Wamboga,Nenad Miljković,Julius Chacha Mwita,Godfrey Mutashambara Rwegerera,Amos Massele,Okwen Patrick,Loveline Lum Niba,Melaine Nsaikila,Wafaa M. Rashed,Mohamed Ali Hussein,Rehab Hegazy,Adefolarin A Amu,Baffour Boaten Boahen-Boaten,Zinhle Matsebula,Prudence Gwebu,Bongani Chirigo,Nongabisa Mkhabela,Tenelisiwe Dlamini,Siphiwe Sithole,Sandile Malaza,Sikhumbuzo Dlamini,Daniel Kwame Afriyie,George A. Asare,Seth Kwabena Amponsah,Israel Abebrese Sefah,Margaret Oluka,Anastasia N. Guantai,Sylvia Opanga,Tebello Violet Sarele,Refeletse Keabetsoe Mafisa,Ibrahim Chikowe,Felix Khuluza,Dan Kibuule,Francis Kalemeera,Mwangana Mubita,Joseph O Fadare,Laurien Sibomana,Gwendoline Malegwale Ramokgopa,Carmen J. Whyte,Tshegofatso C R Maimela,Johannes F.M. Hugo,Johanna C Meyer,Natalie Schellack,Enos M Rampamba,Adel Visser,Abubakr A. Alfadl,Elfatih M. Malik,Oliver Ombeva Malande,Aubrey Chichonyi Kalungia,Chiluba Mwila,Trust Zaranyika,Blessmore Vimbai Chaibva,Ioana D. Olaru,Ioana D. Olaru,Nyasha Masuka,Janney Wale,Lenias Hwenda,Regina Kamoga,Ruaraidh Hill,Corrado Barbui,Tomasz Bochenek,Amanj Kurdi,Amanj Kurdi,Stephen Campbell,Stephen Campbell,Antony P. Martin,Thuy Nguyen Thi Phuong,Binh Nguyen Thanh,Brian Godman +75 more
TL;DR: There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries.
Journal ArticleDOI
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.
Sameer Dhingra,Nor Azlina A Rahman,Ed Peile,Motiur Rahman,Massimo Sartelli,Mohamed Azmi Hassali,Tariqul Islam,Salequl Islam,Mainul Haque +8 more
TL;DR: Suggestions on how to address this public health threat are suggested, including recommendations on training medical students about antibiotics, and strategies to overcome the problems of irrational antibiotic prescribing and AMR are concluded.
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
Brian Godman,Brian Godman,Brian Godman,Björn Wettermark,Björn Wettermark,Menno van Woerkom,Jessica Fraeyman,Samantha Alvarez-Madrazo,Christian Berg,Iain Bishop,Anna Bucsics,Stephen Campbell,Alexander E. Finlayson,Jurij Fürst,Kristina Garuoliene,Harald Herholz,Marija Kalaba,Ott Laius,Jutta Piessnegger,Catherine Sermet,Ulrich Schwabe,Vera Vlahović-Palčevski,Vanda Marković-Peković,Vanda Marković-Peković,Luka Vončina,Kamila Malinowska,Corinne Zara,Lars L. Gustafsson +27 more
TL;DR: In this paper, the influence of multiple supply and demand-side initiatives across Europe for established medicines to enhance prescribing efficiency before a decision to prescribe a particular medicine was assessed, and the authors used the findings to suggest potential future initiatives that countries could consider.
Journal ArticleDOI
Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future
Brian Godman,Debashis Basu,Yogan Pillay,Julius Chacha Mwita,Godfrey Mutashambara Rwegerera,Bene D. Anand Paramadhas,Celda Tiroyakgosi,Patrick Mbah Okwen,Loveline Lum Niba,Justice Nonvignon,Israel Abebrese Sefah,Margaret Oluka,Anastasia N. Guantai,Dan Kibuule,Francis Kalemeera,Mwangana Mubita,Joseph O Fadare,Olayinka O Ogunleye,Larry A. Distiller,Enos M Rampamba,J. R. Wing,Debjani Mueller,Abubakr A. Alfadl,Adefolarin A Amu,Zinhle Matsebula,Aubrey Chichonyi Kalungia,Trust Zaranyika,Nyasha Masuka,Janney Wale,Ruaraidh Hill,Amanj Kurdi,Amanj Kurdi,Angela Timoney,Angela Timoney,Stephen Campbell,Stephen Campbell,Johanna C Meyer +36 more
TL;DR: There are a number of ongoing activities across Africa to improve the management of patients with diabetes including co-morbidities, however, more needs to be done considering the high and growing burden of T2DM in Africa.
Journal ArticleDOI
Strategies to improve antimicrobial utilization with a special focus on developing countries
Brian Godman,Brian Godman,Brian Godman,Abiodun Egwuenu,Mainul Haque,Oliver Ombeva Malande,Natalie Schellack,Santosh Kumar,Zikria Saleem,Jacqueline Sneddon,Iris Hoxha,Salequl Islam,Julius Chacha Mwita,Renata Cristina Rezende Macedo do Nascimento,Isabella Piassi Godói,Isabella Piassi Godói,Loveline Lum Niba,Adefolarin A Amu,Joseph Acolatse,Robert Incoom,Israel Abebrese Sefah,Sylvia Opanga,Amanj Kurdi,Amanj Kurdi,Ibrahim Chikowe,Felix Khuluza,Dan Kibuule,Olayinka O Ogunleye,Adesola Olalekan,Vanda Marković-Peković,Johanna C Meyer,Abubakr A. Alfadl,Thuy Nguyen Thi Phuong,Aubrey Chichonyi Kalungia,Stephen Campbell,Alice Pisana,Janney Wale,R. Andrew Seaton,R. Andrew Seaton +38 more
TL;DR: In this paper, a narrative review of ongoing activities across sectors was undertaken to improve antimicrobial use and address issues with vaccines including COVID-19 pandemic, which resulted in multiple initiatives internationally, nationally and regionally to enhance appropriate antibiotic utilization across sectors to reduce AMR.
References
More filters
A systematic review of the literature
Arindam Basu,Pamela Smartt +1 more
TL;DR: Physicians should consider modification of immunosuppressive regimens to decrease the risk of PTD in high-risk transplant recipients and Randomized trials are needed to evaluate the use of oral glucose-lowering agents in transplant recipients.
Journal ArticleDOI
Antibacterial resistance worldwide: causes, challenges and responses.
Stuart B. Levy,Bonnie Marshall +1 more
TL;DR: The optimism of the early period of antimicrobial discovery has been tempered by the emergence of bacterial strains with resistance to these therapeutics, and today, clinically important bacteria are characterized not only by single drug resistance but also by multiple antibiotic resistance.
Journal ArticleDOI
Antibiotic resistance—the need for global solutions
Ramanan Laxminarayan,Ramanan Laxminarayan,Ramanan Laxminarayan,Adriano Duse,Chand Wattal,Anita K. M. Zaidi,Heiman F. L. Wertheim,Nithima Sumpradit,Erika Vlieghe,Gabriel Levy Hara,Ian M. Gould,Herman Goossens,Christina Greko,Anthony D. So,Maryam Bigdeli,Goeran Tomson,Will Woodhouse,Eva Ombaka,Arturo Quizhpe Peralta,Farah Naz Qamar,Fatima Mir,Sam Kariuki,Zulfigar A. Bhutta,Anthony R.M. Coates,Richard Bergstrom,Gerard D. Wright,Eric D. Brown,Otto Cars +27 more
TL;DR: The global situation of antibiotic resistance, its major causes and consequences, and key areas in which action is urgently needed are described and identified.
Journal ArticleDOI
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
TL;DR: Outpatient antibiotic use in 26 countries in Europe between Jan 1, 1997, and Dec 31, 2002 was investigated by calculating the number of defined daily doses (DDD) per 1000 inhabitants per day according to WHO anatomic therapeutic chemical classification and DDD measurement methodology, and the ecological association between antibiotic use and antibiotic resistance rates was assessed using Spearman's correlation coefficients.
Journal ArticleDOI
Global spread of Carbapenemase-producing Enterobacteriaceae.
TL;DR: These resistance traits have been identified among nosocomial and community-acquired infections and are being investigated for use in drug discovery and development.
Related Papers (5)
Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis.
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Policies for biosimilar uptake in Europe: An overview.
Evelien Moorkens,Arnold G. Vulto,Isabelle Huys,Pieter Dylst,Brian Godman,Brian Godman,Simon Keuerleber,Barbara Claus,Maria Dimitrova,Guenka Petrova,Ljiljana Sović-Brkičić,Juraj Slabý,Robin Šebesta,Ott Laius,Allan Karr,Morgane Beck,Jaana E. Martikainen,Gisbert Selke,Susan Spillane,Laura McCullagh,Gianluca Trifirò,Patricia Vella Bonanno,Asbjørn Mack,Antra Fogele,Anita Viksna,Magdalena Władysiuk,Helder Mota-Filipe,Dmitry Meshkov,Marija Kalaba,Simona Mencej Bedrač,Jurij Fürst,Corrine Zara,Peter Skiold,Einar Magnusson,Steven Simoens +34 more